EoPancreas: New Diabetes Patch Pump and CGM System in Development
FDA has granted "Breakthrough Device Designation" to South Korean company EoFlow, developing a tubeless patch-pump based Automated Insulin Delivery (AID) system.
FDA has granted Breakthrough Device Designation to South Korean company EoFlow, developing a tubeless patch-pump based Automated Insulin Delivery (AID) system.
Diabetes Café (@Diabetesto) / X
December update on closed-loop systems
Quarterly Update Diabetes Technology
Quarterly Update Diabetes Technology
Shop CGM & Pump Underpatches today - Protect your CGM - Trusted by
Medical devices, smart drug delivery, wearables and technology for the treatment of Diabetes Mellitus - ScienceDirect
Shop CGM & Pump Underpatches today - Protect your CGM - Trusted by thousands like you – Type One Style
Omnipod CGM and Pump Patch - Diabetes UK Shop
Medical devices, smart drug delivery, wearables and technology for the treatment of Diabetes Mellitus - ScienceDirect